Bright Minds Biosciences Inc. (DRUG)

Last Closing Price: 25.95 (2025-05-30)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Bright Minds Biosciences Inc. (DRUG) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2024-12-31
Income Statement Financials
--
$0.04M
Cost of Goods Sold
--
--
$1.16M
$-1.16M
$1.20M
$0.04M
$0.04M
$0.04M
$0.04M
$0.04M
$0.04M
$-1.16M
$-1.14M
6.17M
6.64M
$0.01
$0.01
Balance Sheet Financials
$41.58M
--
$0.13M
$41.71M
$0.33M
$0.08M
$0.08M
$0.41M
$41.30M
$41.30M
$41.30M
6.99M
Cash Flow Statement Financials
$-1.07M
--
$37.17M
$4.09M
$41.35M
$37.26M
$0.13M
--
--
Fundamental Metrics & Ratios
126.15
--
--
0.00
0.00
--
--
--
--
--
--
$-1.07M
--
--
--
--
--
--
--
0.09%
0.09%
0.09%
0.09%
$5.91
$-0.16
$-0.16